Literature DB >> 11090500

Treatment of bipolar affective disorder.

A H Young, K A Macritchie, J R Calabrese.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11090500      PMCID： PMC1119052          DOI： 10.1136/bmj.321.7272.1302

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.

Authors:  M A Frye; T A Ketter; T A Kimbrell; R T Dunn; A M Speer; E A Osuch; D A Luckenbaugh; G Cora-Ocatelli; G S Leverich; R M Post
Journal:  J Clin Psychopharmacol       Date:  2000-12       Impact factor: 3.153

2.  A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group.

Authors:  J R Calabrese; T Suppes; C L Bowden; G S Sachs; A C Swann; S L McElroy; V Kusumakar; J A Ascher; N L Earl; P L Greene; E T Monaghan
Journal:  J Clin Psychiatry       Date:  2000-11       Impact factor: 4.384

3.  A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.

Authors:  C L Bowden; J R Calabrese; S L McElroy; L Gyulai; A Wassef; F Petty; H G Pope; J C Chou; P E Keck; L J Rhodes; A C Swann; R M Hirschfeld; P J Wozniak
Journal:  Arch Gen Psychiatry       Date:  2000-05

4.  A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

Authors:  J R Calabrese; C L Bowden; G S Sachs; J A Ascher; E Monaghan; G D Rudd
Journal:  J Clin Psychiatry       Date:  1999-02       Impact factor: 4.384

5.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-17       Impact factor: 79.321

6.  Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial.

Authors:  A L Stoll; W E Severus; M P Freeman; S Rueter; H A Zboyan; E Diamond; K K Cress; L B Marangell
Journal:  Arch Gen Psychiatry       Date:  1999-05

Review 7.  Anticonvulsant therapy and suicide risk in affective disorders.

Authors:  F K Goodwin
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

Review 8.  Psychotherapy for bipolar disorder.

Authors:  J Scott
Journal:  Br J Psychiatry       Date:  1995-11       Impact factor: 9.319

9.  Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.

Authors:  C L Bowden; A M Brugger; A C Swann; J R Calabrese; P G Janicak; F Petty; S C Dilsaver; J M Davis; A J Rush; J G Small
Journal:  JAMA       Date:  1994 Mar 23-30       Impact factor: 56.272

10.  Clozapine for treatment-refractory mania.

Authors:  J R Calabrese; S E Kimmel; M J Woyshville; D J Rapport; C J Faust; P A Thompson; H Y Meltzer
Journal:  Am J Psychiatry       Date:  1996-06       Impact factor: 18.112
  10 in total
  1 in total

1.  Treating bipolar affective disorder. ECT is effective.

Authors:  M Fink
Journal:  BMJ       Date:  2001-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.